+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

2,5-hexanedione (HD) treatment alters calmodulin, Ca2+/calmodulin-dependent protein kinase II, and protein kinase C in rats' nerve tissues

2,5-hexanedione (HD) treatment alters calmodulin, Ca2+/calmodulin-dependent protein kinase II, and protein kinase C in rats' nerve tissues

Toxicology and Applied Pharmacology 232(1): 60-68

Calcium-dependent mechanisms, particularly those mediated by Ca(2+)/calmodulin (CaM)-dependent protein kinase II (CaMKII), have been implicated in neurotoxicant-induced neuropathy. However, it is unknown whether similar mechanisms exist in 2,5-hexanedione (HD)-induced neuropathy. For that, we investigated the changes of CaM, CaMKII, protein kinase C (PKC) and polymerization ratios (PRs) of NF-L, NF-M and NF-H in cerebral cortex (CC, including total cortex and some gray), spinal cord (SC) and sciatic nerve (SN) of rats treated with HD at a dosage of 1.75 or 3.50 mmol/kg for 8 weeks (five times per week). The results showed that CaM contents in CC, SC and SN were significantly increased, which indicated elevation of Ca(2+) concentrations in nerve tissues. CaMKII contents and activities were also increased in CC and were positively correlated with gait abnormality, but it could not be found in SC and SN. The increases of PKC contents and activities were also observed in SN and were positively correlated with gait abnormality. Except for that of NF-M in CC, the PRs of NF-L, NF-M and NF-H were also elevated in nerve tissues, which was consistent with the activation of protein kinases. The results suggested that CaMKII might be partly (in CC but not in SC and SN) involved in HD-induced neuropathy. CaMKII and PKC might mediate the HD neurotoxicity by altering the NF phosphorylation status and PRs.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 051031897

Download citation: RISBibTeXText

PMID: 18582483

DOI: 10.1016/j.taap.2008.05.021

Related references

Full activation of brain calmodulin-dependent protein kinase IV requires phosphorylation of the amino-terminal serine-rich region by calmodulin-dependent protein kinase IV kinase. Journal of Biochemistry 117(4): 686-690, 1995

Components of a calmodulin-dependent protein kinase cascade. Molecular cloning, functional characterization and cellular localization of Ca2+/calmodulin-dependent protein kinase kinase beta. Journal of Biological Chemistry 273(48): 31880-9, 1998

Nitric oxide synthase regulatory sites phosphorylation by cyclic amp dependent protein kinase protein kinase c and calcium calmodulin protein kinase identification of flavin and calmodulin binding sites. Journal of Biological Chemistry 267(16): 10976-10981, 1992

Characterization of a Ca2+/calmodulin-dependent protein kinase cascade. Molecular cloning and expression of calcium/calmodulin-dependent protein kinase kinase. Journal of Biological Chemistry 270(33): 19320-4, 1995

Effect of nitric oxide synthase inhibition on nuclear Ca++/calmodulin-dependent protein kinase IV kinase and nuclear Ca++/calmodulin-dependent protein kinase IV activity during hypoxia in neuronal nuclei of newborn piglets. Pediatric Research 53(4 Part 2): 552A, 2003

Alternative splice variant of gamma-calmodulin-dependent protein kinase II alters activation by calmodulin. Archives of Biochemistry and Biophysics 378(2): 377-383, 2000

Conserved phosphorylation of the intracellular domains of GABA(A) receptor beta2 and beta3 subunits by cAMP-dependent protein kinase, cGMP-dependent protein kinase protein kinase C and Ca2+/calmodulin type II-dependent protein kinase. Neuropharmacology 36(10): 1377-1385, 1997

Cytokinin stimulates calmodulin gene expression and alters calmodulin dependent protein kinase action in plants. Journal of Cellular Biochemistry Suppl. (14 Part C): 149, 1990

Expression of Ca2+/calmodulin-dependent protein kinase types II and IV, and reduced DNA synthesis due to the Ca2+/calmodulin-dependent protein kinase inhibitor KN-62 (1-[N,O-bis(5-isoquinolinesulfonyl)-N-methyl-L-tyrosyl]-4-phenyl piperazine) in small cell lung carcinoma. Biochemical Pharmacology 51(5): 707-715, 1996

Human calcium-calmodulin dependent protein kinase I: cDNA cloning, domain structure and activation by phosphorylation at threonine-177 by calcium-calmodulin dependent protein kinase I kinase. Embo Journal 14(15): 3679-3686, 1995

Characterization of the mechanism of regulation Ca2+/calmodulin-dependent protein kinase I by calmodulin and by Ca2+/ calmodulin-dependent protein kinase kinase. Journal of Biological Chemistry 273(34): 21473-21481, 1998

Phosphorylation and activation of nuclear Ca2+/calmodulin-dependent protein kinase phosphatase (CaMKP-N/PPM1E) by Ca2+/calmodulin-dependent protein kinase I (CaMKI). Biochemical and Biophysical Research Communications 422(4): 703-709, 2012

Phosphorylation of synaptic GTPase-activating protein (synGAP) by Ca2+/calmodulin-dependent protein kinase II (CaMKII) and cyclin-dependent kinase 5 (CDK5) alters the ratio of its GAP activity toward Ras and Rap GTPases. Journal of Biological Chemistry 290(8): 4908-4927, 2015

Phosphorylation of P1, a high mobility group-like protein, catalyzed by casein kinase II, protein kinase C, cyclic AMP-dependent protein kinase and calcium/calmodulin-dependent protein kinase II. Febs Letters 258(1): 106-108, 1989

Ca2+/calmodulin-dependent protein kinase II is an essential mediator in the coordinated regulation of electrocyte Ca2+-ATPase by calmodulin and protein kinase A. Journal of Biological Chemistry 280(34): 30611-8, 2005